Author:
Raffi François,Jaeger Hans,Quiros-Roldan Eugenia,Albrecht Helmut,Belonosova Elena,Gatell Jose M,Baril Jean-Guy,Domingo Pere,Brennan Clare,Almond Steve,Min Sherene
Reference26 articles.
1. Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trial;Eron;Lancet Infect Dis,2011
2. Isentress [package insert],2011
3. Isentress [summary of product characteristics],2011
4. Activity of elvitegravir, a once-daily integrase inhibitor, against resistant HIV type 1: results of a phase 2, randomized, controlled, dose-ranging clinical trial;Zolopa;J Infect Dis,2010
5. Quad's in it for antiretroviral therapy?;Schrijvers;Lancet,2012
Cited by
329 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献